These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 4374227)
1. Evaluation of host immunity in human neoplasia. II. Discussion. Br J Cancer Suppl; 1973 Aug; 1():162-9. PubMed ID: 4374227 [No Abstract] [Full Text] [Related]
3. Cellular immunity to human tumor-associated antigens. A review. Herberman RB Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654 [No Abstract] [Full Text] [Related]
4. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system. Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270 [No Abstract] [Full Text] [Related]
5. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction. Vánky R; Klein E; Stjernswärd J; Nilsonne U Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515 [No Abstract] [Full Text] [Related]
6. Lymphocyte sensitivity and cellular immunity in neoplasia. Faguet GB; Balcerzak SP; Lobuglio AF Biomedicine; 1973 Feb; 19(2):43-7. PubMed ID: 4731978 [No Abstract] [Full Text] [Related]
8. Evaluation of host immunity in human neoplasia. 1. Discussion. Br J Cancer Suppl; 1973 Aug; 1():108-18. PubMed ID: 4804275 [No Abstract] [Full Text] [Related]
9. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma. Chen Z; Shao JB; Wu W Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):570-3. PubMed ID: 14607688 [TBL] [Abstract][Full Text] [Related]
10. Oncofetal antigen-I: distribution in human tumors. Rees WV; Irie RF; Morton DL J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878 [TBL] [Abstract][Full Text] [Related]
11. [Immunological exploration of cancer patients. II. Tumoral immunity]. Cappelaere P; Demaille A; Adenis L Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842 [No Abstract] [Full Text] [Related]
12. [Diagnosis of tumors with the use of immunologic tumor markers]. Vorlaender KO Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301 [No Abstract] [Full Text] [Related]
13. Invited discussion: Tumor-associated antigens and Hodgkin's disease. Hellström KE Natl Cancer Inst Monogr; 1973 May; 36():165-6. PubMed ID: 4126718 [No Abstract] [Full Text] [Related]
14. Significance of serum factors modifying cellular immune responses to growing tumours. Baldwin RW; Price MR; Robins RA Br J Cancer Suppl; 1973 Aug; 1():37-47. PubMed ID: 4374231 [TBL] [Abstract][Full Text] [Related]
15. [Immunosuppression: a paraneoplastic syndrome]. Nagel GA Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773 [No Abstract] [Full Text] [Related]
16. [Carcinoembryonic antigen in oncology]. Tkacheva GA Med Radiol (Mosk); 1983 Aug; 28(8):69-76. PubMed ID: 6310310 [No Abstract] [Full Text] [Related]
17. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases]. Zhukhina GE Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304 [No Abstract] [Full Text] [Related]
18. [Cancer and immunity]. Nagel GA; Geiger C Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152 [No Abstract] [Full Text] [Related]
19. Cellular and humoral immunity to different types of human neoplasms. Hellström I; Hellström KE; Pierce GE; Yang JP Nature; 1968 Dec; 220(5174):1352-4. PubMed ID: 4302696 [No Abstract] [Full Text] [Related]
20. [Development of monoclonal antibodies to human tumor markers]. Yachi A; Imai K; Higashide T Gan To Kagaku Ryoho; 1983 Aug; 10(8):1774-80. PubMed ID: 6309097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]